• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamex Corp. (NASDAQ: STEX) Announces Pre-Sale of Up to $100,000,000 USD for GLDY, a Gold Backed Stablecoin Asset Offering Up to 4.0% Yield

    10/6/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STEX alert in real time by email

    Key Highlights

    • Institutional Scale & Balance-Sheet Alignment: $100,000,000 USD in initial pre-sale capacity with near-term expandable issuance of up to $1.0 billion; Streamex to co-invest with a minimum $5,000,000 USD commitment, demonstrating management alignment and balance-sheet support.

    • Institutional Grade Gold Product with Yield: GLDY is a physical bullion backed stablecoin that delivers up to 4.0% annualized yield (paid in ounces of physical gold) through gold-leasing, combining capital preservation of physical gold with predictable income.

    • Regulated, Institutional Infrastructure: To be launched through the Streamex platform and distributed through institutional channels, GLDY is engineered to meet ETF, asset manager and custody requirements.



    LOS ANGELES, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a vertically integrated commodity tokenization company, today announced an upcoming pre-sale for GLDY, an institutional-grade gold backed stablecoin asset that provides investors with up to 4.0% yield, commencing on or before November 10, 2025.

    "The launch of GLDY represents a major evolution in how investors can access and benefit from physical gold," said Henry McPhie, Co-Founder & CEO of Streamex Corp. "Over $400 billion USD sits in traditional gold ETFs, assets that offer price exposure but cost money to hold and provide no yield. GLDY fundamentally changes that. Now, instead of paying to hold gold, investors can get paid to hold gold. The combination of capital preservation, liquidity, and yield denominated in ounces is purpose-built for portfolio managers, ETFs and institutional balance sheets seeking durable cash management, and diversified commodity exposure. Streamex's meaningful co-investment and launch through our enterprise-grade infrastructure signals our conviction and readiness to scale."

    Product & Market Rationale

    GLDY pairs audited physical gold custody with regulated tokenized securities infrastructure and institutional distribution pathways. Yield generation is achieved through secure gold-leasing agreements providing predictable income while maintaining principal exposure to spot gold. This structure addresses key market needs:

    • Enhanced portfolio construction: yield-bearing gold improves risk-adjusted returns and expands allocation options for fixed-income and multi-asset strategies.  
    • Institutional compliance and custody: engineered to meet custody, audit and reporting standards required by institutional investors and ETF sponsors.  
    • Scalable issuance: initial $100 million USD capacity with rapid scale potential to $1 billion USD reflects Streamex's distribution reach and anticipated institutional appetite.



    How to Participate 

    Interested qualified investors may register interest and schedule a call with the Streamex investor team at https://www.streamex.com/.

    Detailed offering materials, institutional partner announcements and subscription procedures will be provided at launch.

    Investor Participation

    The GLDY pre-sale will be open to qualified investors, including ETFs, institutional investors, and accredited individuals. Streamex will lead the round with a minimum commitment of $5.0 million USD, reflecting its strong confidence in the long-term value of GLDY and alignment with the Company's gold-denominated balance sheet strategy. Participation will require a minimum investment of $200,000 USD for individual investors and $1,000,000 USD for institutional or business entities.

    About GLDY

    GLDY seeks to offer a value that tracks spot gold price and is designed to address the investment and custody requirements of U.S. ETF providers and institutional investors. Each token is backed by physical gold, providing transparent and direct exposure to the underlying asset.

    In addition to spot gold returns, GLDY offers up to 4% annualized yield through the deployment of gold into income-generating leases facilitated by Streamex's exclusive relationship with Monetary Metals. The resulting yield is automatically indexed back into the asset monthly, allowing investors to compound their holdings in gold rather than fiat currency.

    About Streamex Corp.

    Streamex Corp. (NASDAQ:STEX) is a vertically integrated commodity tokenization company focused on bringing real-world assets, particularly gold and other commodities, on chain through regulated, yield-bearing, and liquid financial instruments. With institutional-grade infrastructure and a gold-denominated balance sheet, Streamex is redefining how commodity-based investments are issued, traded, and held in the digital era.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include but are not limited to those regarding the anticipated launch, structure, and capacity of the GLDY pre-sale, the expected yield performance, and the participation of institutional partners. Forward-looking statements are based on assumptions and subject to various risks and uncertainties, many of which are beyond the Company's control, and actual results may differ materially. For further discussion of these risks, please refer to Streamex's filings with the U.S. Securities and Exchange Commission, including the section titled "Risk Factors" in its most recent Annual Report on Form 10-K. Streamex assumes no obligation to update any forward-looking statements except as required by law.

    No Offer or Solicitation

    This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such an offer or solicitation would be unlawful. Any offer of securities will be made only by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

    Contacts

    Streamex Press & Investor Relations

    Adele Carey

    Alliance Advisors Investor Relations

    [email protected]

    [email protected]

    Henry McPhie

    Chief Executive Officer, Streamex Corp.

    [email protected]

    www.streamex.com

    https://x.com/streamex



    Primary Logo

    Get the next $STEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STEX

    DatePrice TargetRatingAnalyst
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Plummer Christine Marie

    4 - Streamex Corp. (0001530766) (Issuer)

    4/17/26 9:45:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Lekstrom Morgan Lee

    4 - Streamex Corp. (0001530766) (Issuer)

    4/17/26 9:45:05 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Mcphie Karl Henry Michael

    4 - Streamex Corp. (0001530766) (Issuer)

    4/17/26 9:45:04 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    SEC Filings

    View All

    Streamex Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    4/10/26 4:24:52 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-K filed by Streamex Corp.

    10-K - Streamex Corp. (0001530766) (Filer)

    3/31/26 5:30:00 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    3/27/26 7:35:16 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

    WINTER PARK, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced webcast details for its earnings and corporate update presentation to be held on Wednesday, April 8, 2026, at 4:30 p.m. EDT. During the webcast, management will provide a recap of the past year, updates on the 2025 financial results, GLDY launch, traction, institutional interest and adoption, continued product development, and the long-term roadmap for 2026 and beyond. A replay of the webcast will be archived on the Company's investor relations website. Details

    4/6/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Highlights Year of Progress, Files Annual Report & Announces Earnings and Corporate Update Presentation

    WINTER PARK, Fla., April 01, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced that it has filed its Annual Report Form 10-K and will host an earnings and corporate update presentation on April 8, 2026. The Company also released a 2025 year-in-review and 2026 subsequent events update highlighting a transformative year of execution and platform development. Key Highlights from the Past Year Strengthened Board and leadership with several key appointments including Mitch Williams, Kevin Gopaul, Shawn Matthews, Anthony Marciano, Christine Plum

    4/1/26 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements

    WINTER PARK, Fla., March 27, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX) today issued a statement to clarify and formally refute a series of third-party posts attributed to S&P Capital IQ and displayed on MarketScreener on March 23, 2026, which referenced the purported expiration on March 24, 2026 of certain lock-up agreements. The Company has determined that the information contained in these posts is materially inaccurate and misleading. Specifically, the referenced aggregate total of 89,833,535 shares of common stock allegedly subject to lock-up agreements and held by executive officers, directors, and certain other security holders in connection

    3/27/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Lekstrom Morgan Lee bought $50,000 worth of shares (20,000 units at $2.50) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    2/18/26 1:41:34 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Large owner Giustra Frank bought $317,000 worth of shares (100,000 units at $3.17) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    2/4/26 7:04:10 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Lekstrom Morgan Lee bought $71,910 worth of shares (23,500 units at $3.06) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    2/3/26 11:32:53 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Appoints Morgan Lekstrom as Executive Chairman, and Announces Completed Repayment of Convertible Debenture and Cancellation of SEPA

    WINTER PARK, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced that its Co-Founder and Chairman, Morgan Lekstrom, has been named Executive Chairman and will join the executive leadership team. The Company has also announced that the previously entered into Secured Convertible Debentures with YA II PN, LTD., a Cayman Islands exempt limited company ("Yorkville" or "Holder") have been fully repaid and the Standby Equity Purchase Agreement (the "SEPA") previously entered into with Yorkville has been cancelled. "I am honoured and excited to step int

    2/9/26 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. (NASDAQ: STEX) Acquires 9.9% Strategic Equity Stake in Royalty and Streaming Firm Empress Royalty Corp. Through a Premium Priced Share-for-Share Transaction at US$5.00 STEX with a Leading Institutional Investment Firm

    LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and real-world asset infrastructure, today announced that it has acquired a 9.9% equity interest in Empress Royalty Corp. ("Empress") (TSXV:EMPR) through a strategic share purchase from Terra Capital Natural Resources Fund Pty Ltd. ("Terra Capital"), a prominent institutional investor. Under the executed Share Purchase Agreement, Streamex acquired 12,671,297 common shares of Empress in exchange for 2,443,750 restricted common shares of Streamex at a US$5.00 STEX share price, representing a premium to the current market price of STEX and an

    12/11/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion

    The launch of Streamex's $100 million USD GLDY pre-sale marks a historic opportunity for gold investors. Investing in gold is no longer just a static store of value, Streamex, through GLDY has created a yield-generating, institutional grade asset designed to offer both spot gold exposure and yield paid in additional ounces of physical gold bullion.  Key Highlights Gold Price Exposure and Gold-Denominated Distributions: GLDY is designed to combine audited physical bullion holdings with yield from institutionally managed gold leases sourced through Monetary Metals. GLDY seeks to provide exposure to the price of gold while targeting periodic distributions paid in additional ounces of gold.Rev

    11/10/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care